John Menditto | Executive Director, IR & Corporate Communications |
David Mazzo | President and CEO |
Joseph Talamo | SVP and CFO |
Doug Losordo | Chief Medical Officer |
Steve Brozak | WBB |
Keay Nakae | Chardan |
Pete Enderlin | MAZ Partners |
Welcome to the Caladrius Biosciences Third Quarter 2018 Financial Results and Business Update Conference Call. Currently, all participants are in a listen-only mode.
Following management's prepared remarks, we will hold a Q&A session. [Operator Instructions].
As a reminder, this call is being recorded today, November 8, 2018.